Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Procedures
6.1 Biliopancreatic Diversion with a Duodenal Switch (BPD-DS)
6.2Adjustable Gastric Bands (AGB)
6.3Vertical Sleeve Gastrectomy (VSG)
6.4 Roux-en-Y Gastric Bypass (RGB)
Chapter 7 Market Segmentation byDevices
7.1 Intragastric Balloons
7.2 Surgical Staples
7.3 Adjustable Gastric Bands
7.4 Sutures
7.5 Gastric Surgery Clamps
7.6 Implantable Gastric Simulators
7.7 Clip Appliers
7.8Bladeless Trocars
Chapter 8 Market Segmentation by Geography
8.1 Europe
8.1.1 Italy
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1Endogastric Solutions, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2 Intuitive Surgical
10.3 TransEnterix
10.4 Spatz Fgia, Inc.
10.5Apollo Endosurgery Inc.
10.6Medtronic
10.7 Aspire Bariatrics
10.8 MID-MED Inc.
10.9 USGI Medical
10.10 Reshape Medical, Inc.
10.11 Johnson& Johnson
10.12ReShape Lifesciences, Inc.
10.13 Cousin Biotech.
10.14Valeant Pharmaceuticals International Inc.
10.15Allergan
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Procedures 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecast by Devices 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
11.1.4 Market Estimates and Forecast by Company 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
